Skip to main content
logo
DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,960
+360 (3.40%)
At close: Sep 4, 2026

DAE HWA Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,4341,654531.42-1,1471,1162,217
Depreciation & Amortization
6,2166,2676,4055,8714,5414,818
Loss (Gain) From Sale of Assets
---18.071.211.07
Asset Writedown & Restructuring Costs
-4,547-4,5473371552,8732,613
Loss (Gain) From Sale of Investments
-576-181.35366.55-381.4766.9-362.47
Loss (Gain) on Equity Investments
-----212.81
Provision & Write-off of Bad Debts
236.44-230.07-158.06441.4-11.4111.02
Other Operating Activities
2,5711,6693,0921,497570.58393.46
Change in Accounts Receivable
-2,4793,33270.05-5,406-2,433-537.21
Change in Inventory
-5,752-4,043-5,043-3,845-4,861923.27
Change in Accounts Payable
-1,453188.1-1,6283,3396,482203.78
Change in Other Net Operating Assets
1,0091,3191,277-756.71-851.72-108.88
Operating Cash Flow
-340.145,4285,250-214.418,19310,386
Operating Cash Flow Growth
-3.39%---21.11%291.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,161-2,836-4,374-8,907-27,690-9,684
Sale of Property, Plant & Equipment
----27.341.06
Sale (Purchase) of Intangibles
-1,412-1,891-1,770-2,030-4,247-4,712
Investment in Securities
-155.6540.4810,244-4,3116,663-3,277
Other Investing Activities
5-201,17029-18
Investing Cash Flow
-3,723-4,2075,270-15,220-25,247-17,654

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-81,31139,85066,24149,30347,507
Long-Term Debt Issued
-10,1459,0008,38118,5115,047
Total Debt Issued
90,97491,45648,85074,62267,81452,554
Short-Term Debt Repaid
--83,491-55,117-52,339-46,751-31,972
Long-Term Debt Repaid
--6,706-5,042-2,013-1,403-13,735
Total Debt Repaid
-83,703-90,197-60,158-54,353-48,154-45,707
Net Debt Issued (Repaid)
7,2721,259-11,30820,27019,6606,848
Dividends Paid
-2,647-2,627-2,627-2,627-2,627-2,623
Other Financing Activities
-75.7364.42-151.19-608.05-708.673,573
Financing Cash Flow
4,549-1,004-14,08717,03416,3247,798

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
549.67-518.16876.61-375.86-147.0461.21
Miscellaneous Cash Flow Adjustments
-0-00-0--0
Net Cash Flow
1,036-301.78-2,6911,224-876.6591.24

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,5012,591875.3-9,122-19,497701.81
Free Cash Flow Growth
-196.06%----
Free Cash Flow Margin
-1.68%1.81%0.59%-6.45%-14.78%0.60%
Free Cash Flow Per Share
-139.86147.8349.41-520.75-1113.0840.20
Levered Free Cash Flow
-2,4242,409-1,953-10,874-26,251-10,965
Unlevered Free Cash Flow
623.895,4051,458-7,953-24,773-10,016

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4,3354,5175,4984,4952,8151,342
Cash Income Tax Paid
3,4013,115-307.58280.762,0401,181
Change in Working Capital
-8,674796.32-5,325-6,668-1,664480.96